Evidence for oxidative activation of mitoxantrone in human, pig, and rat.
A new metabolite of mitoxantrone in human, rat, and pig urine has been discovered by means of HPLC. The metabolite has been isolated by preparative HPLC from patient urine and is characterized by tandem mass spectrometry and UV-visible spectroscopy as 8,11-dihydroxy-4-(2-hydroxyethyl)-6-[[2-[(2-hydroxyethyl)amino]ethyl] amino]-1,2,3,4,7,12-hexahydronaphtho-[2,3-f]-chinoxaline-7,1 2-dione. Final structural proof has been obtained by independent synthesis. The new metabolite is a product of the enzymatic oxidation of the phenylenediamine substructure of mitoxantrone. An important biological consequence of the oxidative biotransformation is the possibility of covalent binding to intracellular targets via a highly electrophilic intermediate. Thus, alkylation may be an important mode of action of mitoxantrone. Incubation of mitoxantrone with horseradish peroxidase/hydrogen peroxide in the presence of glutathione led to the formation of two glutathione conjugates of mitoxantrone. Their structures have been elucidated by combination of IonSpray (Sciex, Canada) ionization and tandem mass spectrometry. Radioactive mitoxantrone, synthesized from sodium [14C]cyanide, was used to determine interspecies variations between human and rat. The collected rat urine was analyzed by HPLC using a radioactivity monitoring detector and revealed significant differences in the biotransformation of mitoxantrone in rat compared to human. The main metabolites thus far described in human urine are not observed in rat urine.
Blanz
J
J
Institut für Organische Chemie, Universität Tübingen.
Mewes
K
K
Ehninger
G
G
Proksch
B
B
Waidelich
D
D
Greger
B
B
Zeller
K P
KP
D000818:Animals; D001711:Biotransformation / Q000502:physiology; D001826:Body Fluids / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid / Q000295:instrumentation; D005978:Glutathione / Q000378:metabolism; D006735:Horseradish Peroxidase / Q000378:metabolism; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D013058:Mass Spectrometry; D008942:Mitoxantrone / Q000031:analogs & derivatives / Q000737:chemistry / Q000302:isolation & purification / Q000493:pharmacokinetics* / Q000652:urine; D015394:Molecular Structure; D010084:Oxidation-Reduction; D051381:Rats; D011919:Rats, Inbred Strains; D013045:Species Specificity; D013053:Spectrophotometry / Q000379:methods; D013552:Swine; D013556:Swine, Miniature
C072955:8,11-dihydroxy-4-(2-hydroxyethyl)-6-((2-((2-hydroxyethyl)amino)ethyl)amino)-1,2,3,4,7,12-hexahydronaphtho(2,3-f)quinoxaline-7,12-dione; D008942:Mitoxantrone; D006735:Horseradish Peroxidase; D005978:Glutathione